Annual Drug Patent Expirations for GLUMETZA Glumetza is a drug marketed by Santarus Inc and is included in one NDA. It is available from two suppliers. There are two patents…
The post New patent expiration for Santarus Inc drug GLUMETZA appeared first …
New patent expiration for Santarus Inc drug GLUMETZA Read Post »
REYVOW (lasmiditan succinate) Eli lilly and co Patent: 8,748,459 Expiration: Mar 27, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,…
The post Drug Patent Expirations for the We…
Drug Patent Expirations for the Week of March 26, 2023 Read Post »
Annual Drug Patent Expirations for REYVOW Reyvow is a drug marketed by Eli Lilly And Co and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Eli Lilly drug REYVOW appeared first on DrugPatentWatch…
Annual Drug Patent Expirations for AFINITOR+DISPERZ Afinitor Disperz is a drug marketed by Novartis Pharm and is included in one NDA. It is available from one supplier. There are two…
The post New patent expiration for Novartis Pharm drug AFINITOR DISP…
New patent expiration for Novartis Pharm drug AFINITOR DISPERZ Read Post »
Annual Drug Patent Expirations for AFINITOR+DISPERZ Afinitor Disperz is a drug marketed by Novartis Pharm and is included in one NDA. It is available from one supplier. There are two…
The post New patent expiration for Novartis Pharm drug AFINITOR DISP…
New patent expiration for Novartis Pharm drug AFINITOR DISPERZ Read Post »
Annual Drug Patent Expirations for VENLAFAXINE+BESYLATE Venlafaxine Besylate is a drug marketed by Almatica and is included in one NDA. It is available from one supplier. There are two patents…
The post New patent expiration for Almatica drug VENLAFAXI…
New patent expiration for Almatica drug VENLAFAXINE BESYLATE Read Post »
Annual Drug Patent Expirations for ABILIFY Abilify is a drug marketed by Otsuka and Otsuka Pharm Co Ltd and is included in six NDAs. It is available from one supplier.…
The post New patent expiration for Otsuka drug ABILIFY appeared first on DrugPatent…
Annual Drug Patent Expirations for XELJANZ+XR Xeljanz Xr is a drug marketed by Pfizer and is included in one NDA. It is available from two suppliers. There are five patents…
The post New patent expiration for Pfizer drug XELJANZ XR appeared first on Dr…
New patent expiration for Pfizer drug XELJANZ XR Read Post »
Annual Drug Patent Expirations for XELJANZ Xeljanz is a drug marketed by Pfizer and Pf Prism Cv and is included in three NDAs. It is available from two suppliers. There…
The post New patent expiration for Pf Prism drug XELJANZ appeared first on DrugPat…
Annual Drug Patent Expirations for TRELEGY+ELLIPTA Trelegy Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are fifteen patents…
The post New patent expiration for Glaxosmithkline drug T…
New patent expiration for Glaxosmithkline drug TRELEGY ELLIPTA Read Post »